1. 1. Greco M. Development and supply of vaccines: an industry perspective. In: Levine MM, Kaper JB, Rappuoli R, et al., eds. New Generation Vaccines. 3rd ed. New York: Marcel Dekker Inc., 2004:75–87. 2. Womack JP, Jones DT, Roos D. The machine that changed the world. New York: Rawson, 1990. 3. ICH Harmonised Tripartite Guideline. Available at: http://www. ich.org/lob/media/media1957.pdf. Accessed October 2007. 4. European Commission. Working party on control of medicines and inspections. Available at: http://ec.europa.eu/enterprise/ pharmaceuticals/eudralex/vol-4/pdfs-en/v4an15.pdf. Accessed October 2007. 5. Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Manufacturing/QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM071836. Accessed September 2009. 6. Available at: http://www.fda.gov/cder/gmp/gmp2004/ risk_based.pdf Accessed September 2009. 7. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070305.pdf. Accessed September 2009. 8. Wassard K, Monge M. Rapid implementation of a smallpox vaccine facility. Bioprocess Int 2007; 5(suppl 4):32–37. 9. Scott C. Disposables qualification and process validation. Managing risk to address leachables, extractables, and more. Bioprocess Int 2007; (suppl 4):24–27. 10. De Waele K, Vandermarliere M, von Broekhoven A, et al. A novel single-use mixing system for buffer preparation. Bioprocess Int 2007; (suppl 4):56–61. 11. Scott C. Single-use bioreactors. Bioprocess Int Suppl Series 2007; (suppl 4):44–51. 12. Pora H. Improving speed and quality in vaccine production. Pharm Technol Europe 2007; 19(3):33–34. 13. Kinney SD, Phillips CW, Lin KJ. Thermoplastic tubing welders and sealers. Bioprocess Int 2007; (suppl 4):52–55. 14. Milstien J, Candries B. Economics of vaccine development and implementation: changes over the past 20 years. The Jordan Report 20th Anniversary. Accelerated Development of Vaccines, U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, 2002:73–79. 15. Available at: http://www.prlog.org/10232681-the-worldwidemarket-for-vaccines-to-reach-US507-billion-in-2013-forecastsnew-report.html. Accessed September 2009. 16. Wyeth 2008 Financial Report (2008). Company Data by Reportable Segment (p. 43). 17. GAVI. Global vaccine supply: the changing role of suppliers. Available at: http://www.gavialliance.org/resources/BCG_24_June.pdf. Accessed: October 2007. 18. Milstien JB, Dellepiane N, Belgharbi L, Chocarro L, Wood D. Assuring Vaccine Quality by Strengthening Regulatory Agencies: The Work of the World Health Organization. In: Levine MM, Dougan G, Good MF, et al., eds. New Generation Vaccines. 4th ed. New York: Informa Healthcare USA, Inc. 2009:121–130. 19. Milstien JB, Gaule P, Kaddar M. Access to vaccine technologies in developing countries: Brazil and India. Vaccine 2007; 25(44): 7610–7619. 20. Frewe SE, Rezaie R, Sammut SM, et al. India’s health biotech sector at a crossroads. Nat Biotechnol 2007; 21(4):403–417.